Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on ...

Overall, Novo is expecting slower growth in 2025. The company is guiding for sales to rise between 16% and 24%, down from 26% ...

The Trump Administration is reportedly mulling over a policy to match U.S. drug prices with those in other developed nations.

Drugmakers have been warned that the Trump Administration is considering linking U.S. medicine prices to lower amounts paid ...

CompanyOverview|NYSE:MDT] Investors increasingly seek stable and resilient investments in today's volatile and economically ...

Westbury’s school district is continuing its tradition of leveraging lawsuits to advocate for the school’s community.

A unique Novo Nordisk legal challenge to the Medicare drug pricing program could have big implications for the pharma ...

President Donald Trump's latest executive order outlines the administration's plan to lower costs for healthcare. The plan ...

Eli Lilly’s shares shot up 11% pre-market on Thursday after orforglipron became the first small-molecule GLP-1 drug to ace a ...

Growth is driven by the rising prevalence of diabetes among the elderly, necessitating efficient insulin delivery solutions ...

Gluco Armor’s Liquid Formula Emerges as a Natural, Science-Backed Solution for Blood Sugar Support, Offering a Functional ...

Arlington-based Texas Health Resources is suing six drugmakers and pharmacy benefit managers, alleging the parties colluded to drive up the price of insulin, according to court documents obtained by ...